Trial Profile
A study to evaluate the effects of exenatide and liraglutide on metabolic and renal function parameters in overweight patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 Mar 2016 New trial record